Publication | Closed Access

Induction-concurrent chemoradiotherapy with or without sintilimab in patients with locoregionally advanced nasopharyngeal carcinoma in China (CONTINUUM): a multicentre, open-label, parallel-group, randomised, controlled, phase 3 trial

Radiation TherapyMedicineAdvanced Nasopharyngeal CarcinomaInduction-concurrent ChemoradiotherapyCancer TreatmentOncologyRadiation OncologyPhase 3RadiologyHealth Sciences